Choose a country to view content specific to your location
Choose a country to view content specific to your location
Renowned gastroenterologists Dr. Steven F. Moss (Brown University) and Dr. Colin W. Howden (University of Tennessee) will review the latest recommendations on who, how, and when to test for H. pylori, including newly identified patient groups. They will also discuss a clinical case on managing infection.
The program covers prevalence, key disease associations, current non-invasive testing guidance, and updated treatment strategies, highlighting the “Test–Treat–Retest” approach to improve patient outcomes.
Speaker: Dr. Steven Moss and Dr. Colin Howden
Join Dr. M. Aamir Ali, MD, for an enlightening webinar on ‘Current Trends in H. pylori Testing: Disease State and Diagnostic Modalities.’ In this session, Dr. Ali will explore the latest advancements in testing for Helicobacter pylori, a key factor in various gastric conditions. Learn about the evolving landscape of diagnostic techniques, their accuracy, and how they can be effectively applied in clinical practice to improve patient outcomes. This webinar is ideal for healthcare professionals seeking to enhance their knowledge on H. pylori, including its impact on gastrointestinal health and the most effective diagnostic tools available today.
Disclaimer: This is an archived webinar and treatment recommendations may not reflect 2024 ACG/AGA guidelines.
Speaker: M. Aamir Ali, MD
Presented by Margie Morgan, PhD D(ABMM), Professor of Pathology and Laboratory Medicine Cedars-Sinai Medical Center, Los Angeles, CA
Speaker: Margie Morgan PhD, D (ABMM), Professor of Pathology and Laboratory Medicine. Cedars- Sinai Medical Center, Los Angeles, CA
C. difficile key opinion leader Wallace Greene, PhD, (ABMM) presents the topic -Detecting Clostridium difficile and addressing what are the recommendations and what are your options for testing.
Speaker: Wallace Greene, PhD, (ABMM) Director, Diagnostic Virology Laboratory, Department of Pathology, Penn State Hershey Medical Center
Malgré la stratégie de dépistage universel entre la 35 et 37ème semaine de grossesse, le streptocoque du groupe B (SGB) reste la cause majeure de méningite et de sepsis néonatal précoce. Un groupe d’experts Européens à recommandé un déplacement du dépistage à l’accouchement avec un test PCR rapide.
2 expertes des CNR France et Belgique discuteront des différents défis du diagnostic du SGB, de l’intérêt du dépistage intrapartum et des résultats d’une étude multicentrique portant sur le dépistage intrapartum à l’aide du test rapide moléculaire Revogene® GBS DS (Meridian Bioscience).
Speaker:
Dr. Asmaa Tazi – MCU-PH laboratoire de bactériologie de l’hôpital Cochin – APHP/CNR Français des Streptocoques
Cécile Meex – Ph.Biol. Service de Microbiologie Clinique du CHU Liège/CNR Belge Streptococcus agalactiae
Speaker: Jean-Marc Senterre, MD, Laboratory deputy director, Microbiology Service Chief, Liege – Belgium
Speaker: Cedric Pritchett MD, MPH, FAAP, FACS
The problem is much bigger than you think. 1 in 200 babies are born with Congenital Cytomegalovirus (cCMV). It is the leading cause of deafness in babies born in the United States. Of the 90% that are born asymptomatic, 43% will pass the hearing test even though they are infected with congenital CMV. This webinar will review the disease state of congenital CMV, including incidence, importance of early detection, diagnosis, and disease management which can impact patient outcome.
Speaker: Shannon A. Ross, MD, MSPH. Pediatric Infectious Diseases. The University of Alabama at Birmingham
Meridian offers diagnostic manufacturers the complete solution with over 3,000 antigens and antibodies covering more than 500 diseases and an extensive range of specialty qPCR/RT-qPCR master mixes and molecular enzymes all manufactured under ISO13485 regulations.
Have questions about a product? Want to learn more about Meridian’s molecular or immunoassay reagent portfolio? We want to hear from you!
